> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# House Hearing Planned on Generic and Biosimilar User Fees
- URL: https://www.fdaweb.com/house-hearing-planned-on-generic-and-biosimilar-user-fees/
- Published: 2017-02-23T12:00:00.000Z
- Updated: 2026-09-14T22:08:17.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5138057

The House Energy and Commerce health subcommittee has announced a 3/2 [hearing](http://links.govdelivery.com/track?type=click&enid=ZWFzPTEmbXNpZD0mYXVpZD0mbWFpbGluZ2lkPTIwMTcwMjIzLjcwMzczODgxJm1lc3NhZ2VpZD1NREItUFJELUJVTC0yMDE3MDIyMy43MDM3Mzg4MSZkYXRhYmFzZWlkPTEwMDEmc2VyaWFsPTE2ODM3NjQ0JmVtYWlsaWQ9ZGF2aWRAZmRhd2ViLmNvbSZ1c2VyaWQ9ZGF2aWRAZmRhd2ViLmNvbSZ0YXJnZXRpZD0mZmw9JmV4dHJhPU11bHRpdmFyaWF0ZUlkPSYmJg==&&&100&&&https://energycommerce.house.gov/hearings-and-votes/hearings/examining-fda-s-generic-drug-and-biosimilar-user-fee-programs&ref=fdaweb.com) on “Examining FDA’s Generic Drug and Biosimilar User Fee Programs.” The hearing is part of the reauthorization process as both programs are set to expire 9/30\. FDA and relevant stakeholders will provide testimony on how the programs have been implemented to date and present recommendations on their reauthorization. The subcommittee will also consider HR 749, the Lower Drug Costs Through Competition Act, [bipartisan legislation to increase competition in the pharmaceutical industry](http://links.govdelivery.com/track?type=click&enid=ZWFzPTEmbXNpZD0mYXVpZD0mbWFpbGluZ2lkPTIwMTcwMjIzLjcwMzczODgxJm1lc3NhZ2VpZD1NREItUFJELUJVTC0yMDE3MDIyMy43MDM3Mzg4MSZkYXRhYmFzZWlkPTEwMDEmc2VyaWFsPTE2ODM3NjQ0JmVtYWlsaWQ9ZGF2aWRAZmRhd2ViLmNvbSZ1c2VyaWQ9ZGF2aWRAZmRhd2ViLmNvbSZ0YXJnZXRpZD0mZmw9JmV4dHJhPU11bHRpdmFyaWF0ZUlkPSYmJg==&&&101&&&https://www.wsj.com/articles/house-lawmaker-pushes-bill-to-rein-in-drug-prices-1486038607&ref=fdaweb.com).